TY  - JOUR

T1  - Response to treatment in the Multiple Symptoms Study 3 trial – Authors' reply

JO  - The Lancet

UR  - https://doi.org/10.1016/s0140-6736(25)00330-7

PY  - 2025/04/05

AU  - Burton C

AU  - Deary V

AU  - Mooney C

AU  - Sutton L

AU  - Cooper C

ED  - 

DO  - DOI: 10.1016/s0140-6736(25)00330-7

PB  - Elsevier BV

VL  - 405

IS  - 10485

SP  - 1146

EP  - 1146

Y2  - 2025/04/21

ER  -